Study: Risk of developing heart condition from COVID-19 vaccine is rare
The group studied over 2 million people who received at least one dose of the Pfizer and Moderna vaccine.
•
Oct 5, 2021, 10:03 AM
•
Updated 1,025 days ago
Share:
More Stories
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago1:25
Pharmacies say they have not received orders for newest COVID booster
303ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago0:41
Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days
317ds ago2:13
NYSDOH: COVID numbers up with new variant accounting for 17% of new cases
351ds ago2:30
NYSHD: Hospitalizations caused by COVID increase by 22% in a week
358ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago1:25
Pharmacies say they have not received orders for newest COVID booster
303ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago0:41
Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days
317ds ago2:13
NYSDOH: COVID numbers up with new variant accounting for 17% of new cases
351ds ago2:30
NYSHD: Hospitalizations caused by COVID increase by 22% in a week
358ds agoResearch shows the risk of
developing a heart condition after receiving a COVID-19 vaccine is rare.
The research was just
published by a group of doctors at Kaiser Permanente.
The group studied over 2
million people who received at least one dose of the Pfizer and Moderna
vaccine.
Researchers say 15 people
developed myocarditis, a kind of heart inflammation.
The study showed all 15 cases
were in men between the ages of 20 and 32 years old.
